↓ Skip to main content

Long-range regulators of the lncRNA HOTAIR enhance its prognostic potential in breast cancer

Overview of attention for article published in Human Molecular Genetics, July 2016
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
4 X users

Citations

dimensions_citation
57 Dimensions

Readers on

mendeley
50 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Long-range regulators of the lncRNA HOTAIR enhance its prognostic potential in breast cancer
Published in
Human Molecular Genetics, July 2016
DOI 10.1093/hmg/ddw177
Pubmed ID
Authors

Michael J.G. Milevskiy, Fares Al-Ejeh, Jodi M. Saunus, Korinne S. Northwood, Peter J. Bailey, Joshua A. Betts, Amy E. McCart Reed, Kenneth P. Nephew, Andrew Stone, Julia M.W. Gee, Dennis H. Dowhan, Eloise Dray, Annette M. Shewan, Juliet D. French, Stacey L. Edwards, Susan J. Clark, Sunil R. Lakhani, Melissa A. Brown

Abstract

Predicting response to endocrine therapy and survival in estrogen receptor positive breast cancer is a significant clinical challenge and novel prognostic biomarkers are needed. Long-range regulators of gene expression are emerging as promising biomarkers and therapeutic targets for human diseases, so we have explored the potential of distal enhancer elements of non-coding RNAs in the prognostication of breast cancer survival. HOTAIR is a long non-coding RNA that is overexpressed, promotes metastasis and is predictive of decreased survival. Here we describe a long-range transcriptional enhancer of the HOTAIR gene that binds several hormone receptors and associated transcription factors, interacts with the HOTAIR promoter and augments transcription. This enhancer is dependent on Forkhead-Box transcription factors and functionally interacts with a novel alternate HOTAIR promoter. HOTAIR expression is negatively regulated by estrogen, positively regulated by FOXA1 and FOXM1, and is inversely correlated with estrogen receptor and directly correlated with FOXM1 in breast tumors. The combination of HOTAIR and FOXM1 enables greater discrimination of endocrine therapy responders and non-responders in patients with estrogen receptor positive breast cancer. Consistent with this, HOTAIR expression is increased in cell-line models of endocrine resistance. Analysis of breast cancer gene expression data indicates that HOTAIR is co-expressed with FOXA1 and FOXM1 in HER2-enriched tumors, and these factors enhance the prognostic power of HOTAIR in aggressive HER2+ breast tumors. Our study elucidates the transcriptional regulation of HOTAIR, identifies HOTAIR and its regulators as novel biomarkers of patient response to endocrine therapy and corroborates the importance of transcriptional enhancers in cancer.

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 50 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 50 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 10 20%
Researcher 9 18%
Student > Ph. D. Student 6 12%
Student > Master 5 10%
Student > Doctoral Student 2 4%
Other 4 8%
Unknown 14 28%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 17 34%
Agricultural and Biological Sciences 8 16%
Medicine and Dentistry 4 8%
Pharmacology, Toxicology and Pharmaceutical Science 3 6%
Immunology and Microbiology 2 4%
Other 2 4%
Unknown 14 28%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 July 2016.
All research outputs
#14,571,801
of 23,339,727 outputs
Outputs from Human Molecular Genetics
#6,430
of 8,070 outputs
Outputs of similar age
#206,205
of 355,905 outputs
Outputs of similar age from Human Molecular Genetics
#69
of 116 outputs
Altmetric has tracked 23,339,727 research outputs across all sources so far. This one is in the 35th percentile – i.e., 35% of other outputs scored the same or lower than it.
So far Altmetric has tracked 8,070 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.0. This one is in the 18th percentile – i.e., 18% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 355,905 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 39th percentile – i.e., 39% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 116 others from the same source and published within six weeks on either side of this one. This one is in the 37th percentile – i.e., 37% of its contemporaries scored the same or lower than it.